drugset / Trial / NCT07462507
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
NaSingle-groupOpen-labelDiagnostic
Summary
Adult patients with primary or secondary central nervous system malignancies will be invited to undergo a baseline \[C-11\]-CS1P1 PET scan and a follow-up scan within 24 months of the baseline scan (preferably within 6-months post-treatment).The study will describe patterns of tracer uptake in tumors and normal brain and explore how these patterns relate to MRI findings, treatments received, and clinical outcomes.
Timeline
- Start
- 2026-04-16
- Primary completion
- 2031-06-30
- Completion
- 2033-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [C-11]-CS1P1 | Diagnostic / imaging agent | — | Intravenous |